Shanghai HeartCare Medical Technology Corporation Limited (HeartCare-B) disclosed no change in its Hong Kong-listed H-share capital but confirmed the issuance of 1.00 million new unlisted ordinary shares on 29 June 2026.

• H-shares: Outstanding listed shares remained at 30.59 million, with 0.97 million held as treasury shares. No issuance, cancellation or repurchase occurred during the period from 31 May 2026 to 29 June 2026.

• Unlisted shares: The company issued 1.00 million new shares at HKD 45.00 each under a subscription agreement approved by shareholders on 16 January 2026. The allotment expanded the unlisted share base by 13.76%, lifting it from 7.27 million to 8.27 million shares.

• Capital structure post-transaction: Total issued shares across all classes (including treasury shares) rose to approximately 39.83 million. Treasury shares remain unchanged at 0.97 million.

The board confirmed that the share issuance complied with all Hong Kong Stock Exchange listing rules and applicable regulatory requirements, and that full consideration of roughly HKD 45.00 million was duly received.